Search - tctmd.com

Displaying 1 - 20 of 58

Sort: Relevancy | Date

Presentation TCT 2016

Transcatheter Tricuspid Valve Therapies 6: Cardioband TR Description, Results and a Case

Presenter: Joachim Schofer, Alec S. Vahanian, Karl-Heinz Kuck

November 01, 2016

Presentation TCT 2016

Valtech TMVR: Design Development Update

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Karl-Heinz Kuck

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty VI: Cardiac Implants

Presenter: Ted Feldman, Scott Lim, Karl-Heinz Kuck

October 31, 2016

Presentation TCT 2016

TCT 41: Up to Two Years Follow-up Results of Mitral Valve Transcatheter Annuloplasty System for Mitral Reconstruction Multicenter Trial

Presenter: Stephan Baldus, Allan Schwartz, Karl-Heinz Kuck

October 31, 2016

Presentation TCT 2016

Pacing-based Treatments of Hypertension: BackBeat Medical

Presenter: Ajay J. Kirtane, Bryan Williams, Karl-Heinz Kuck

October 30, 2016

Presentation TCT 2016

Risk Scores for Stroke Risk and Bleeding in Atrial Fibrillation: Accuracy and Utility in Trials and the Real World

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Christopher B. Granger

October 30, 2016

Presentation TCT 2016

Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Vivek Y. Reddy

October 30, 2016

Presentation TCT 2016

What are Valid Absolute and Relative Contraindications to Warfarin and NOACs?

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt

October 30, 2016

Presentation TCT 2016

Warfarin and NOACS for Atrial Fibrillation: Efficacy, Complications, and Compliance

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Michelle O'Donoghue

October 30, 2016

Presentation TCT 2016

Impact of LAA Exclusion on Neurohormonal Modulation

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt

October 30, 2016

Presentation TCT 2016

Role of LAA in Atrial Arrhythmias: Origin and Maintenance

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt

October 30, 2016

Presentation TCT 2016

Atrial Fibrillation: Scope of the Problem

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Michael D. Ezekowitz

October 30, 2016

Presentation TCT 2016

Access Site Alternatives for Transcatheter MV Replacement: Transatrial, Transapical, or Transfemoral/Transsseptal?

Presenter: Michael J. Mack, Francesco Maisano, Karl-Heinz Kuck

October 30, 2016

News Conference News PCR London Valves 2016

Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies

Shelley Wood

September 19, 2016

Presentation TVT 2016

Cardiac Implant Complete Ring

Presenter: Karl-Heinz Kuck

June 17, 2016

Presentation TVT 2016

Cardioband: Device, Outcomes, and Similarities and Differences Compared With Surgery

Presenter: Karl-Heinz Kuck

June 17, 2016

Presentation TVT 2016

Annuloplasty: The Next Frontier

Presenter: Karl-Heinz Kuck

June 17, 2016

News Conference News ACC 2016

Cardioband Transcatheter Mitral Annulus Repair Appears Safe, Effective in Functional MR

Shelley Wood

April 07, 2016

Presentation TCT 2015

Cardioband: Device Description, Latest Data, and Future Directions

Presenter: Steven L. Goldberg, Joachim Schofer, Karl-Heinz Kuck

October 14, 2015

Presentation TCT 2015

The Tables Turned: MitraClip After Failed Surgical Annuloplasty for Secondary MR

Presenter: Stephan Baldus, Saibal Kar, Karl-Heinz Kuck

October 14, 2015

Advertisement

Transcatheter Tricuspid Valve Therapies 6: Cardioband TR Description, Results and a Case

Valtech TMVR: Design Development Update

Direct Annuloplasty VI: Cardiac Implants

TCT 41: Up to Two Years Follow-up Results of Mitral Valve Transcatheter Annuloplasty System for Mitral Reconstruction Multicenter Trial

Pacing-based Treatments of Hypertension: BackBeat Medical

Risk Scores for Stroke Risk and Bleeding in Atrial Fibrillation: Accuracy and Utility in Trials and the Real World

Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation

What are Valid Absolute and Relative Contraindications to Warfarin and NOACs?

Warfarin and NOACS for Atrial Fibrillation: Efficacy, Complications, and Compliance

Impact of LAA Exclusion on Neurohormonal Modulation

Role of LAA in Atrial Arrhythmias: Origin and Maintenance

Atrial Fibrillation: Scope of the Problem

Access Site Alternatives for Transcatheter MV Replacement: Transatrial, Transapical, or Transfemoral/Transsseptal?

Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies

Cardiac Implant Complete Ring

Cardioband: Device, Outcomes, and Similarities and Differences Compared With Surgery

Annuloplasty: The Next Frontier

Cardioband Transcatheter Mitral Annulus Repair Appears Safe, Effective in Functional MR

Cardioband: Device Description, Latest Data, and Future Directions

The Tables Turned: MitraClip After Failed Surgical Annuloplasty for Secondary MR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content